Kancera AB (publ) (KAN) - Total Liabilities

Latest as of June 2025: Skr3.58 Million SEK ≈ $385.05K USD

Based on the latest financial reports, Kancera AB (publ) (KAN) has total liabilities worth Skr3.58 Million SEK (≈ $385.05K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore KAN cash flow conversion to assess how effectively this company generates cash.

Kancera AB (publ) - Total Liabilities Trend (2010–2024)

This chart illustrates how Kancera AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Check Kancera AB (publ) (KAN) asset resilience to evaluate the company's liquid asset resilience ratio.

Kancera AB (publ) Competitors by Total Liabilities

The table below lists competitors of Kancera AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Ion Energy Ltd V:ION	Canada	CA$1.29 Million
TCI Finance Limited NSE:TCIFINANCE	India	Rs828.64 Million
Bluejay Diagnostics Inc NASDAQ:BJDX	USA	$1.14 Million
Tessin Nordic Holding AB ST:TESSIN	Sweden	Skr219.97 Million
MEP Infrastructure Developers Limited NSE:MEP	India	Rs35.65 Billion
EF EnergyFunders Ventures Inc V:EFV	Canada	CA$9.35 Million
Epwin Group PLC LSE:EPWN	UK	GBX193.00 Million
Pineapple Financial Inc. NYSE:PAPL	USA	$3.86 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Kancera AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see KAN company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kancera AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kancera AB (publ) (2010–2024)

The table below shows the annual total liabilities of Kancera AB (publ) from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr4.61 Million ≈ $496.22K	-74.35%
2023-12-31	Skr17.98 Million ≈ $1.93 Million	+30.03%
2022-12-31	Skr13.83 Million ≈ $1.49 Million	+27.19%
2021-12-31	Skr10.87 Million ≈ $1.17 Million	+0.47%
2020-12-31	Skr10.82 Million ≈ $1.16 Million	-59.83%
2019-12-31	Skr26.93 Million ≈ $2.90 Million	+121.21%
2018-12-31	Skr12.18 Million ≈ $1.31 Million	-2.70%
2017-12-31	Skr12.51 Million ≈ $1.35 Million	-7.35%
2016-12-31	Skr13.51 Million ≈ $1.45 Million	+146.21%
2015-12-31	Skr5.49 Million ≈ $590.38K	-39.92%
2014-12-31	Skr9.13 Million ≈ $982.64K	+36.43%
2013-12-31	Skr6.69 Million ≈ $720.27K	-49.18%
2012-12-31	Skr13.17 Million ≈ $1.42 Million	-4.82%
2011-12-31	Skr13.84 Million ≈ $1.49 Million	+370.04%
2010-12-31	Skr2.94 Million ≈ $316.82K	--

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#29694 Global

#693 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr2.00

All Time High

Skr38.15